Stem’s main risk is sequencing: liquidity has to hold long enough for the software-and-services model to prove it can generate durable cash. If operating cash flow misses, the balance sheet can force
dilution or defensive financing before improving mix, utility-scale conversions, and higher-value modules have time to matter. Competition is real, but financing pressure is the nearer governor on upside.